CRP and Rare hereditary thrombophilia: Also indicating better RBC quality were biomarkers of hemolysis, thrombophilia, and inflammation, namely serum LDH, total bilirubin, D-dimer, and CRP levels, all of which improved in cohorts 4 and 5 (Fig 7D–7G, S1 Fig, S1 Data).